Innate Immunity and MASLD
Metabolic dysfunction-associated steatotic liver disease (MASLD) has emerged as the most common liver disease worldwide in recent years. MASLD commonly presents as simple hepatic steatosis, but ~25% of patients develop liver inflammation, progressive fibrosis, liver cirrhosis and related hepatocellu...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI AG
2024-04-01
|
| シリーズ: | Biomolecules |
| 主題: | |
| オンライン・アクセス: | https://www.mdpi.com/2218-273X/14/4/476 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
